Directory
>
Conor Gallagher
Conor Gallagher
Chief Scientific Officer | Revance Therapeutics, Inc.
San Francisco, California, United States
Conor Gallagher
Summary
Conor Gallagher is an accomplished Chief Scientific Officer at Revance Therapeutics, Inc., with extensive experience in the pharmaceutical and medical sectors. He has a strong background in clinical development, drug development, and medical affairs, particularly within dermatology and aesthetics. With a PhD in Neuroscience from the University of Toronto and a history of leadership roles at Allergan, Conor has a proven track record of driving scientific innovation and market access strategies. His expertise spans various therapeutic areas, including oncology and immunology, showcasing his versatility in the medical field. Conor is known for his strategic vision and ability to lead cross-functional teams in complex environments. His commitment to advancing medical science is evident through his years of dedicated research and clinical trial management. He has a passion for mentoring the next generation of scientists and contributing to the evolving landscape of healthcare.
Conor Gallagher
Work Experience
Chief Scientific Officer at
Revance Therapeutics, Inc.
March 2024 - Present
Vice President Medical Affairs and Scientific Innovation at
REVANCE THERAPEUTICS LTD
April 2018 - February 2024
Executive Director, Medical Affairs, Global Lead Facial Aesthetics at
AbbVie
January 2017 - March 2018
Sr. Medical Director, Facial Aesthetics at
AbbVie
March 2016 - January 2017
Medical Director, Facial Aesthetics and Medical Dermatology at
AbbVie
July 2012 - March 2016
Director, Global Neurotoxin Science, Medical Affairs at
AbbVie
November 2008 - July 2012
Regional Scientific Services Manager at
AbbVie
December 2005 - November 2008
Postdoctoral Fellow at
The Hospital for Sick Children
January 2003 - December 2005
Conor Gallagher
Education
January 1996 - January 2002
University College Cork, M.Sc.
January 1994 - January 1995
University College Dublin, B.Physio. (Hons)
January 1988 - January 1992
Frequently Asked Questions about Conor Gallagher
What is Conor Gallagher email address?
Conor Gallagher's primary email address is **********@revance.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Conor Gallagher work for?
Conor Gallagher is a Chief Scientific Officer at Revance Therapeutics, Inc., a company specializing in Commercial physical research.
Where Conor Gallagher graduated from?
Conor Gallagher holds a degree in Neuroscience from University of Toronto.
How can I directly contact Conor Gallagher?
To contact Conor Gallagher directly, you can use the email address **********@revance.com. Complete contact information is available upon registration with Muraena.
Is Conor Gallagher an immigrant?
Yes, Conor Gallagher is an immigrant and currently based in United States
Who is Conor Gallagher?
Conor Gallagher is an accomplished Chief Scientific Officer at Revance Therapeutics, Inc., with extensive experience in the pharmaceutical and medical sectors. He has a strong background in clinical development, drug development, and medical affairs, particularly within dermatology and aesthetics. With a PhD in Neuroscience from the University of Toronto and a history of leadership roles at Allergan, Conor has a proven track record of driving scientific innovation and market access strategies. His expertise spans various therapeutic areas, including oncology and immunology, showcasing his versatility in the medical field. Conor is known for his strategic vision and ability to lead cross-functional teams in complex environments. His commitment to advancing medical science is evident through his years of dedicated research and clinical trial management. He has a passion for mentoring the next generation of scientists and contributing to the evolving landscape of healthcare.
Conor`s contact details
**********@revance.com
***********@utoronto.ca
***************@allergan.com
***********@alumni.utoronto.ca
Colleagues
Vice President, International Marketing & Public Relations l Global Market Strategy
Executive Director, QC
Vice President, Marketing (April 2017-Jan. 2024) Launch & Strategy Consultant (Feb. 2024-Present)
Vice President, Clinical Operations
President & CEO
Executive Director Facilities, Engineering, EH&S
Chief Legal Officer, General Counsel & Corporate Secretary
Vice President, Clinical Development and Data Science
Executive Director IT, R&D and CSV
VP Corporate Controller